🧠 neuroscience
Anti-amyloid immunotherapy drives APOE4 specific increases in glial reactivity, perivascular immune activation, and ARIA-like events
Using the EFAD mouse model, this study demonstrates that anti-amyloid immunotherapy triggers APOE4-specific increases in glial reactivity, perivascular immune activation, and ARIA-like microhemorrhages due to unique vascular susceptibility, highlighting critical immunological targets for mitigating treatment risks in APOE4 carriers.
Pallerla, A. V., Lucido, C. C., Saito, K., Nolt, G. L., Arbones-Mainar, J. M., Funnell, J. L., Satish, D., Smith, L. M. (…)2026-06-29